Mark Cuban says startup founders face a cash crisis no public-market billionaire does, and that asymmetry shapes his loudest objection yet to Proposition 40, a California ballot measure with more than $100 million already…
IBM just posted its worst mainframe quarter in years, a securities fraud inquiry is hanging over management, and the stock sits nearly 20% below its 52-week high. So why are the franchise's most important…
Apple just posted its strongest June quarter ever and still watched shares sink 7% in a single day. Something underneath the headline numbers is quietly breaking down, and the October earnings report could expose…
A crypto influencer with half a million followers just put a bold XRP price target on the record and told his audience to save the prediction. Three reasons back it up, but the numbers…
The Fed's rate cuts have quietly killed the easy income trade, and chasing 6% now means choosing between credit risk, structural complexity, and duration bets that each blow up under a different scenario.
A surprise authorization on a massive satellite program sent Intuitive Machines surging while every space peer sat completely still, raising a pointed question about what this company knows that the rest of the sector…
Amazon briefly touched $3 trillion before pulling back, and a $4 billion insider sale spooked the market just as AWS posted its fastest growth in 18 quarters. Whether that retreat is a warning sign…
Costco's business keeps compounding while its stock sits frozen, and that tension between a thriving membership flywheel and a stretched valuation has analysts split on whether the current price is an opportunity or a…
Bill Ackman told CNBC that a billionaire tax turns failed entrepreneurs into lifelong government debtors, but the proposal he described and the one actually on California's ballot may not be the same thing.
Every time Broadcom slides, one investor hits buy without hesitation, and the reasoning behind that reflex goes deeper than a simple dip-buying instinct.
A newly public biotech is betting its entire future on a single antibody platform designed to silence the cytokine scientists call the itch cytokine, and its pipeline already stretches from skin disease into inflammatory…
Tesla just posted record deliveries and a massive revenue beat while simultaneously cratering its own earnings and flipping free cash flow negative. Wall Street's 47 analysts cannot agree on what that contradiction means, and…
Wall Street is pricing Alphabet like a company losing the AI race, but a quiet milestone suggests the market may be making a very expensive mistake.
Wall Street's most dominant process control chipmaker just dropped nearly 10% in a month despite a five-quarter beat streak, and one high-conviction analyst sees a gap forming that the rest of the Street has…
Turning 55 with a thin retirement balance feels like arriving late to a race with no shortcut, but three ETFs are quietly becoming the go-to toolkit for savers who need growth, income, and damage…
